Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy
Advanced Functional Materials · 2024-04 · 34 (17)
DOI: 10.1002/adfm.202314536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 02.01.2024. Verfasst von Zichuang Xu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gas therapy, represented by nitric oxide (NO), has shown a powerful anti‐tumor effect. However, current NO therapy relies on NO precursors, which are often released prematurely during in vivo delivery, resulting in poor targeting and obvious toxic side effects. Herein, a core/shell‐structured nanocatalyst is designed and prepared to catalyze the generation of NO in tumor without introduction of NO donor. In this system, C‐Z@CM is prepared by coating the octahedron of Cu‐MOF with a nano‐ZnO, and camouflaging homologous tumor cell membrane. After the nanomedicine is taken up by tumor cells, ZnO reacts in situ with endogenous S‐nitrosoglutathione (GSNO), which is highly expressed in tumors, to continuously and stably generate NO. In addition, the dispersed copper ions in C‐Z@CM acts as the catalytic active centers of the Fenton‐like reaction, which catalyzes H 2 O 2 to generate a large number of hydroxyl radicals ( • OH). Importantly, the cascade of NO and reactive oxygen species (ROS) leads to the massive production of more lethal reactive nitrogen species (RNS), further enhancing the therapeutic effect. Catalytic production of high concentrations of NO in situ in the tumor, combined with the cascade generation of ROS and RNS, accompanied by glutathione (GSH) depletion, achieving effective tumor suppression.
Förderung
- Natural Science Foundation of Hebei Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, Z., Luo, Q., He, Y., He, Y., Zhang, X., Wang, J., Ni, S., Gao, D., & Wang, D. (2024). Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy. Advanced Functional Materials, 34(17). https://doi.org/10.1002/adfm.202314536
Vancouver
Xu Z, Luo Q, He Y, He Y, Zhang X, Wang J, et al. Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy. Advanced Functional Materials. 2024;34(17). doi:10.1002/adfm.202314536
BibTeX
@article{Xu2024,
author = {Xu, Zichuang and Luo, Qingzhi and He, Yaqian and He, Yuchu and Zhang, Xuwu and Wang, Jing and Ni, Song and Gao, Dawei and Wang, Desong},
title = {Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {17},
doi = {10.1002/adfm.202314536}
}
EUVIMED